Intestinal transplantation from living donors

M. Tuveri, Luca Cicalese, S. Pisu

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Intestinal transplantation (ITx) represents the physiologic alternative to total parenteral nutrition (TPN) for patients suffering from life-threatening complications of irreversible intestinal failure. The number of transplants performed worldwide has been increasing for several years until recently. ITx has recently become a valid therapeutic option with a graft survival rate between 80 % and 90 % at 1 year, in experienced centers. These results have been achieved due to a combination of several factors: Better understanding of the pathophysiology of intestinal graft, improved immunosuppression techniques, more efficient strategies for the monitoring of the bowel graft, as well as control of infectious complications and posttransplant lymphoproliferative disease (PTLD). In fact, this procedure is associated with a relatively high rate of complications, such as infections, acute rejection, graft versus host disease (GVHD), and PTLD, if compared to the transplantation of other organs. These complications may be, at least in part, the consequence of the peculiarity of this graft, which contains gut-associated lymphoid tissue and potentially pathogenic enteric flora. Furthermore, in these patients, the existing disease and the relative malnutrition could predispose them to infectious complications. Additionally, other factors associated with the procedure, such as laparotomy, preservation injury, abnormal motility, and lymphatic disruption, could all be implicated in the development of complications.

Original languageEnglish (US)
Title of host publicationLiving Donor Advocacy: An Evolving Role Within Transplantation
PublisherSpringer New York
Pages41-74
Number of pages34
ISBN (Print)9781461491439, 9781461491422
DOIs
StatePublished - Jan 1 2014

Fingerprint

Living Donors
Transplantation
Transplants
Total Parenteral Nutrition
Organ Transplantation
Lymphoid Tissue
Graft vs Host Disease
Graft Survival
Malnutrition
Laparotomy
Immunosuppression
Survival Rate
Wounds and Injuries
Infection
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tuveri, M., Cicalese, L., & Pisu, S. (2014). Intestinal transplantation from living donors. In Living Donor Advocacy: An Evolving Role Within Transplantation (pp. 41-74). Springer New York. https://doi.org/10.1007/978-1-4614-9143-9_4,

Intestinal transplantation from living donors. / Tuveri, M.; Cicalese, Luca; Pisu, S.

Living Donor Advocacy: An Evolving Role Within Transplantation. Springer New York, 2014. p. 41-74.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tuveri, M, Cicalese, L & Pisu, S 2014, Intestinal transplantation from living donors. in Living Donor Advocacy: An Evolving Role Within Transplantation. Springer New York, pp. 41-74. https://doi.org/10.1007/978-1-4614-9143-9_4,
Tuveri M, Cicalese L, Pisu S. Intestinal transplantation from living donors. In Living Donor Advocacy: An Evolving Role Within Transplantation. Springer New York. 2014. p. 41-74 https://doi.org/10.1007/978-1-4614-9143-9_4,
Tuveri, M. ; Cicalese, Luca ; Pisu, S. / Intestinal transplantation from living donors. Living Donor Advocacy: An Evolving Role Within Transplantation. Springer New York, 2014. pp. 41-74
@inbook{af09f9dc190f4c42994248f64c129428,
title = "Intestinal transplantation from living donors",
abstract = "Intestinal transplantation (ITx) represents the physiologic alternative to total parenteral nutrition (TPN) for patients suffering from life-threatening complications of irreversible intestinal failure. The number of transplants performed worldwide has been increasing for several years until recently. ITx has recently become a valid therapeutic option with a graft survival rate between 80 {\%} and 90 {\%} at 1 year, in experienced centers. These results have been achieved due to a combination of several factors: Better understanding of the pathophysiology of intestinal graft, improved immunosuppression techniques, more efficient strategies for the monitoring of the bowel graft, as well as control of infectious complications and posttransplant lymphoproliferative disease (PTLD). In fact, this procedure is associated with a relatively high rate of complications, such as infections, acute rejection, graft versus host disease (GVHD), and PTLD, if compared to the transplantation of other organs. These complications may be, at least in part, the consequence of the peculiarity of this graft, which contains gut-associated lymphoid tissue and potentially pathogenic enteric flora. Furthermore, in these patients, the existing disease and the relative malnutrition could predispose them to infectious complications. Additionally, other factors associated with the procedure, such as laparotomy, preservation injury, abnormal motility, and lymphatic disruption, could all be implicated in the development of complications.",
author = "M. Tuveri and Luca Cicalese and S. Pisu",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-9143-9_4,",
language = "English (US)",
isbn = "9781461491439",
pages = "41--74",
booktitle = "Living Donor Advocacy: An Evolving Role Within Transplantation",
publisher = "Springer New York",

}

TY - CHAP

T1 - Intestinal transplantation from living donors

AU - Tuveri, M.

AU - Cicalese, Luca

AU - Pisu, S.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Intestinal transplantation (ITx) represents the physiologic alternative to total parenteral nutrition (TPN) for patients suffering from life-threatening complications of irreversible intestinal failure. The number of transplants performed worldwide has been increasing for several years until recently. ITx has recently become a valid therapeutic option with a graft survival rate between 80 % and 90 % at 1 year, in experienced centers. These results have been achieved due to a combination of several factors: Better understanding of the pathophysiology of intestinal graft, improved immunosuppression techniques, more efficient strategies for the monitoring of the bowel graft, as well as control of infectious complications and posttransplant lymphoproliferative disease (PTLD). In fact, this procedure is associated with a relatively high rate of complications, such as infections, acute rejection, graft versus host disease (GVHD), and PTLD, if compared to the transplantation of other organs. These complications may be, at least in part, the consequence of the peculiarity of this graft, which contains gut-associated lymphoid tissue and potentially pathogenic enteric flora. Furthermore, in these patients, the existing disease and the relative malnutrition could predispose them to infectious complications. Additionally, other factors associated with the procedure, such as laparotomy, preservation injury, abnormal motility, and lymphatic disruption, could all be implicated in the development of complications.

AB - Intestinal transplantation (ITx) represents the physiologic alternative to total parenteral nutrition (TPN) for patients suffering from life-threatening complications of irreversible intestinal failure. The number of transplants performed worldwide has been increasing for several years until recently. ITx has recently become a valid therapeutic option with a graft survival rate between 80 % and 90 % at 1 year, in experienced centers. These results have been achieved due to a combination of several factors: Better understanding of the pathophysiology of intestinal graft, improved immunosuppression techniques, more efficient strategies for the monitoring of the bowel graft, as well as control of infectious complications and posttransplant lymphoproliferative disease (PTLD). In fact, this procedure is associated with a relatively high rate of complications, such as infections, acute rejection, graft versus host disease (GVHD), and PTLD, if compared to the transplantation of other organs. These complications may be, at least in part, the consequence of the peculiarity of this graft, which contains gut-associated lymphoid tissue and potentially pathogenic enteric flora. Furthermore, in these patients, the existing disease and the relative malnutrition could predispose them to infectious complications. Additionally, other factors associated with the procedure, such as laparotomy, preservation injury, abnormal motility, and lymphatic disruption, could all be implicated in the development of complications.

UR - http://www.scopus.com/inward/record.url?scp=84956526064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956526064&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-9143-9_4,

DO - 10.1007/978-1-4614-9143-9_4,

M3 - Chapter

SN - 9781461491439

SN - 9781461491422

SP - 41

EP - 74

BT - Living Donor Advocacy: An Evolving Role Within Transplantation

PB - Springer New York

ER -